Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bevacizumab

Interstitial pneumonia: case report

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Huober J, Schoch O, Templeton A, Spirig C, Thurlimann B.Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer. Chemotherapy (Basel) 56: 69-70, No. 1, Apr 2010. Available from: URL: http://dx.doi.org/10.1159/000282286 - Switzerland

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Bevacizumab. React. Wkly. 1308, 12 (2010). https://doi.org/10.2165/00128415-201013080-00026

    Download citation

    Keywords

    • Breast Cancer
    • Doxorubicin
    • Bevacizumab
    • Prednisone
    • Lung Function